22157.jpg
Major Musculoskeletal Pain Markets Forecast to Reach $5.39 Billion by 2034 - Insights on Epidemiology, Pipeline Drugs, Trends, Unmet Needs, Sales, Major Players, and More
13 juin 2024 05h00 HE | Research and Markets
Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Musculoskeletal Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...
22157.jpg
Burn Pain Markets: Epidemiology, Trends, Shares, Drug Sales, Growth Opportunities, and Forecast 2024-2034
30 mai 2024 07h37 HE | Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Burn Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...
22157.jpg
DSUVIA (sufentanil) Drug Insights and U.S. Market Analysis, 2023-2032
30 janv. 2024 08h01 HE | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "United States DSUVIA Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This extensive report...
22157.jpg
MAXIGESIC IV Drug Insight and U.S. Market Forecasts to 2032: In-depth Product Overview, Regulatory Milestones, Competitive Landscape Analysis, and SWOT Analysis
29 janv. 2024 12h15 HE | Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "United States MAXIGESIC IV Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Dual Mode-of-Action...
22157.jpg
ANJESO Drug Insight and Market Forecast in the United States, 2023-2032: Developmental Milestones, Intellectual Property Insights, Future Market Forecast, and SWOT Analysis with Sales Projections
29 janv. 2024 12h14 HE | Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "United States ANJESO Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This comprehensive report...
22157.jpg
United States OLINVYK Drug Insight and Market Forecasts, 2019-2032: A Novel G Protein-biased (selective) Mu-opioid Receptor (MOR) Ligand Approved to Manage Acute Pain
24 janv. 2024 07h43 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "United States OLINVYK Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides...
22157.jpg
Global Pain Therapeutics Market to 2029 - Featuring Abbott Laboratories, AstraZeneca and GlaxoSmithKline Among Others
28 mars 2022 07h33 HE | Research and Markets
Dublin, March 28, 2022 (GLOBE NEWSWIRE) -- The "Pain Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts,...